Key areas of Research

Feasibility of the investigators and the institution done in several clinical trials in the treatment of various cancers including Breast cancer and lung cancer, awaiting the IERB dates.

Title: “An Open – Label Multicentric Randomized, Two Treatment, Two Period Two Sequence Cross – over, single Dose, Bioequivalence Study of Test Melphalan 50mg powder for solution for infusion Manufactured by Sindan – Pharma SRL, Romania for Actavis Group PTC ehf Iceland with Reference Alkeran ( Melphalan) 50mg Powder and Solvent for Solution for Infusion Manufactured by Aspen Pharma, Ireland in Patients with Advanced Ovarian Cancer”

© 2022 St John's Medical College all rights reserved | Designed by INTEGRO